Medication is a vital and powerful resource in global healthcare. However, improper medication use through its dose, storage and prescription can be destructive to health. For example, the World Health Organization reports that 50% of overall preventable harm in medical care is due to medication harm.
The Obstetric and Pediatric Pharmacology section of Frontiers in Pharmacology would like to build on the awareness of this excellent initiative through a themed article collection, recognizing the importance of medication safety in these populations.
This collection aims to highlight the advancements made in obstetric and pediatric pharmacotherapy and the safety of medicines in treating and preventing diseases during pregnancy and childhood.
This collection will welcome the following article types: Brief Research Report, Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Review, Study Protocol, Systematic Review, Technology and Code.
In this Research Topic, we welcome manuscripts in the broader field of pediatric and obstetric clinical pharmacology and pharmacovigilance with a focus on the following subjects:
• Innovative or current algorithms used for identifying and collecting safety events data
• Validation of safety databases and application of data analysis algorithms
• Utilization of safety data using electronic medical records to improve clinical care and clinical research or trials
• Drug safety studies in pediatric and obstetric populations
We encourage submissions from research networks, academics, regulatory agencies, policy-makers, pharmaceutical companies, and other institutions interested in safety data in pediatric and obstetric populations. We welcome full research papers, brief reports, systematic reviews, other review papers and correspondences from areas of data collection, development of algorithms, and integration into electronic health records related to safety data associated with pharmacology in pediatric and obstetric populations.
Medication is a vital and powerful resource in global healthcare. However, improper medication use through its dose, storage and prescription can be destructive to health. For example, the World Health Organization reports that 50% of overall preventable harm in medical care is due to medication harm.
The Obstetric and Pediatric Pharmacology section of Frontiers in Pharmacology would like to build on the awareness of this excellent initiative through a themed article collection, recognizing the importance of medication safety in these populations.
This collection aims to highlight the advancements made in obstetric and pediatric pharmacotherapy and the safety of medicines in treating and preventing diseases during pregnancy and childhood.
This collection will welcome the following article types: Brief Research Report, Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Review, Study Protocol, Systematic Review, Technology and Code.
In this Research Topic, we welcome manuscripts in the broader field of pediatric and obstetric clinical pharmacology and pharmacovigilance with a focus on the following subjects:
• Innovative or current algorithms used for identifying and collecting safety events data
• Validation of safety databases and application of data analysis algorithms
• Utilization of safety data using electronic medical records to improve clinical care and clinical research or trials
• Drug safety studies in pediatric and obstetric populations
We encourage submissions from research networks, academics, regulatory agencies, policy-makers, pharmaceutical companies, and other institutions interested in safety data in pediatric and obstetric populations. We welcome full research papers, brief reports, systematic reviews, other review papers and correspondences from areas of data collection, development of algorithms, and integration into electronic health records related to safety data associated with pharmacology in pediatric and obstetric populations.